关于怀孕不良结果的第一季度预测模型 - - 实施预防心血管疾病发展战略的基础
Ilona Hromadnikova1, Katerina Kotlabova1, Ladislav Krofta2
1Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University, Prague, Czechia.
Frontiers in cell and developmental biology
|September 19, 2024
概括
使用miRNA生物标志物和母亲临床数据,可以对不良妊娠结果进行早期预测. 这些模型可以整合到第一季度查中,以实现及时干预和降低风险.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 产科 产科 产科 产科 产科
背景情况:
- 怀孕不良后果对健康构成重大风险.
- 早期识别高风险怀孕对于干预至关重要.
- 微RNAs (miRNAs) 显示出作为妊娠并发症早期生物标志物的潜力.
研究的目的:
- 开发高效,具有成本效益和早期预测模型来预测不良妊娠结果.
- 为了确定一组最小的miRNA生物标志物与预测的母亲临床特征相结合.
- 评估这些模型在各种妊娠队列中的预测性能.
主要方法:
- 单独怀孕的回顾性研究,包括各种不良结果和正常对照.
- 使用实时逆转录聚合酶链反应 (RT-PCR) 在妊娠10-13周之间对外静脉血液的MiRNA基因表达概况.
- 开发结合精选miRNA和母亲临床数据的预测模型.
主要成果:
- 对于妊娠高血压 (69.88%),孕前 (83.33%),HELLP综合征 (92.86%),胎儿生长限制 (73.17%),妊娠年龄小 (81.08%),妊娠糖尿病 (89.47%) 和晚期流产 (84.85%) 实现了高预测准确度.
- 死亡出生预测仅使用miRNA生物标志物,没有额外的临床特征,实现了高检测率 (91.67%).
- 这些模型显示了早期识别有风险的怀孕的巨大潜力.
结论:
- 结合与心血管疾病相关的miRNAs和孕产妇临床变量的模型为不良妊娠结果提供了高预测潜力.
- 这些模型可以整合到常规的第一季度查计划中.
- 早期识别有助于通过生活方式干预减轻心血管风险和相关疾病的预防计划.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
64
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
420
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
420